Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000377775 | SCV000332062 | benign | not specified | 2015-06-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000631511 | SCV000752593 | benign | Osteogenesis imperfecta type I | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001124861 | SCV001283862 | likely benign | Osteogenesis imperfecta | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001124862 | SCV001283863 | uncertain significance | Ehlers-Danlos syndrome, arthrochalasia type | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001124863 | SCV001283864 | uncertain significance | Infantile cortical hyperostosis | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Gene |
RCV001711850 | SCV001941272 | likely benign | not provided | 2020-12-30 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 21884818) |
Ce |
RCV001711850 | SCV002545949 | benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | COL1A1: BS1, BS2 |
Genome Diagnostics Laboratory, |
RCV001124861 | SCV002565115 | likely benign | Osteogenesis imperfecta | 2021-10-13 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278262 | SCV002565460 | likely benign | Ehlers-Danlos syndrome | 2022-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002411144 | SCV002721392 | benign | Cardiovascular phenotype | 2020-07-21 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004547656 | SCV004737143 | likely benign | COL1A1-related disorder | 2019-05-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |